OUR SPEAKERS 邀請講者

2024_TSIR_座長_張維洲

國防醫學院放射診斷學系 系主任

Wei-Chou Chang

  • 國防醫學院放射診斷學系 系主任
  • 美國加州大學舊金山分校 (UCSF) 研究員
  • 台北三軍總醫院放射診斷部 部主任
  • 講者簡介 BIOGRAPHY
    • 國防醫學院 醫學系
    • 國立陽明交通大學生物影像暨放射線學系博士
    • 美國加州大學舊金山分校 (UCSF) 研究員
    • 台北三軍總醫院放射診斷部 部主任
    講者經歷 ACHIEVEMENTS & HONORS
  • Zhang TT, Chang WC, Wang ZJ, Sun DC, Ohliger MA, Yeh BM. Bowel Wall Visualization Using MR Enterography in Relationship to Bowel Lumen Contents and Patient Demographics. J Magn Reson Imaging. 2021;54(3):728-736.
  • Chang WC, Hsu HH, Chiu SH, et al. Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads. J Hepatocell Carcinoma. 2021;8:937-949.
  • Chiu SH, Shih YL, Huang GS, Chang PY, Lin HH, Chang WC, Hsu HH, Kao HW. Time to peak enhancement of malignant hypervascular hepatic tumors versus that of the aorta evaluating by test bolus sequence of magnetic resonance imaging. Eur J Radiol. 2020 (Correspondence)
  • Chang WC, M Yeh B, Chu L, Kim SY, Wen KW, Chiu SH, Ding CC, Wu EH, Roberts JP, Huang GS, Hsu HH. Post-operative assessment in patients after liver transplantation: imaging parameters associated with 1-year graft failure. Eur Radiol. 2021;31(2):764-774. (Correspondence)
  • Chen PK, Chiu SH, Tsai MT, Chang KH, Chang WC, Lin HH, Lo CH, Huang GS, Chang PY. Combination therapy of sorafenib and drug-eluting bead transarterial chemoembolization for advanced hepatocellular carcinoma with and without hepatic arteriovenous shunt. J Chin Med Assoc 2022 Apr 1;85(4):491-499. (Correspondence)